/ Guides / Mazdutide

Mazdutide: the complete guide.

New to peptides and Mazdutide keeps coming up next to Tirzepatide and Retatrutide? This is the plain-English walkthrough: what it is, how people take it, how to mix and dose it, and how to buy it without getting burned. No jargon, no hype, just the honest picture.

12 min read

The short version.

If you read nothing else, read this. The whole guide in a handful of bullets.

The short version
  • What it is: Mazdutide is a once-weekly peptide that activates two receptors at once, the GLP-1 receptor and the glucagon receptor. It is a dual agonist developed for obesity and type 2 diabetes.
  • What people run it for: weight loss, with an added metabolic angle, since the glucagon arm is studied for raising energy expenditure on top of the appetite suppression GLP-1 drugs are known for.
  • Typical dose: a slow titration from about 1.5 mg weekly up through 3 mg and 4.5 mg to a 4 to 6 mg maintenance dose, with trials reaching 9 mg.
  • Routes: subcutaneous injection once a week is the standard, and the only practical route. It is not an oral peptide.
  • Cycle: run continuously while titrating up, the same as other GLP-1 type compounds, rather than in short on-off blocks.
  • Honest caveat: the human data is real but comes from manufacturer trials in Chinese adults, and mazdutide is approved only in China, not the FDA or EMA. It is sold for research use only, and this is not medical advice.

Quick reference.

Typical dose1.5 mg start, titrate to 4 to 6 mg weekly
RoutesSubcutaneous injection, once weekly
FrequencyOnce a week, same day each week
Cycle lengthRun continuously while titrating, not short blocks
Best forWeight loss with an added energy-expenditure angle

What is Mazdutide?

Mazdutide is a peptide, which simply means a small chain of amino acids, the same building blocks that make up the proteins in your body. It was developed by Innovent and Eli Lilly under the code IBI362, and it belongs to the newest generation of weight-loss compounds.

What makes it different is that it is a dual agonist. Instead of acting on one target, it switches on two receptors at the same time: the GLP-1 receptor, which curbs appetite and slows the stomach, and the glucagon receptor, which is studied for raising the rate at which the body burns energy. Most weight-loss drugs only do the first part.

The version sold by peptide vendors arrives as a freeze-dried white powder in a small sealed vial. It is not a steroid, not a stimulant, and not a stomach stapler in a needle. People reach for it because it is studied for one theme above all: substantial weight loss, with the glucagon arm adding a metabolic angle that pure GLP-1 drugs lack.

Worth saying plainly: mazdutide is approved as a medicine only in China, and it is not approved by the FDA or EMA. The peptide vendors we compare sell it strictly for research use only, and the human data comes almost entirely from manufacturer-run trials. We get into what that means further down.

How it works in the body.

You do not need a biology degree to follow this. Here is the simple picture, then a little more for the curious.

The core idea is that mazdutide pulls two levers at once. One reduces how much you eat, the other is studied for increasing how much energy you spend, and together they are meant to do more than either alone.

  • GLP-1 receptor (eat less). This is the familiar arm. It curbs appetite, slows how fast the stomach empties, and supports a healthier insulin response, so you feel full on less food.
  • Glucagon receptor (burn more). This is the part that sets mazdutide apart. Glucagon receptor activation is studied for raising fat oxidation and energy expenditure, so weight can come off through spending more, not just eating less.
  • Balanced by design. Glucagon on its own would raise blood sugar, but the GLP-1 arm counteracts that. The molecule is tuned so the two effects work together rather than against each other.
Honest caveat: the human evidence is real and published, but it comes overwhelmingly from trials run by the manufacturer in Chinese adults, and mazdutide is approved only in China. Treat the explanations above as what mazdutide is studied for, not as settled outcomes that apply to everyone everywhere.

How to take it: routes of administration.

Mazdutide is an injectable peptide. Like the other GLP-1 type compounds, it is not a meaningful oral option, so the real choice is just where you inject. Here is the honest comparison.

RouteTypical doseAbsorptionBest forDifficulty
Subcutaneous1.5 to 6 mgReliable, systemicStandard weekly dosingTiny needle, easy to learn
IntramuscularNot standardHighNot recommendedUnnecessary and more invasive
OralNot practicalVery lowNot recommendedPoorly absorbed
Route 01

Subcutaneous injection

Dose1.5 to 6 mg
WhereBelly or thigh
AbsorptionReliable, systemic

The standard route by far, and really the only sensible one. A tiny insulin needle goes into the fat just under the skin, not into muscle. It is a once-weekly shot, far less intimidating than it sounds, and the same routine as semaglutide or tirzepatide.

Route 02

Intramuscular

DoseNot standard
Wheren/a
AbsorptionHigh

There is no reason to inject mazdutide into muscle. It is designed for slow, steady subcutaneous absorption over a week, and intramuscular dosing only adds discomfort with no benefit. Skip it.

Route 03

Oral

DoseNot practical
Formn/a
AbsorptionVery low

Mazdutide is a peptide that does not survive digestion, so there is no practical oral version. Stick to the once-weekly subcutaneous injection.

Where to inject.

If you go this route, these are the sites people use. Rotate so no single area gets sore.

Human body outline showing subcutaneous injection sites

The easiest spots are the belly (about 2 inches either side of the navel), the love handles, the front of the thigh, and the back of the upper arms. Rotate every injection.

So which should a beginner pick? There is really only one answer: subcutaneous, once a week. Absorption is reliable, the needle is tiny, and it matches how the compound was studied. Intramuscular and oral are not options worth chasing.

Our full step-by-step injection how-to and the dosage calculator live on the Mazdutide product page. This guide covers the concepts; that page is where you work out your exact units.

Reconstitution: mixing it.

Mazdutide arrives as a dry powder, so before you can inject it you reconstitute it, which just means adding liquid to turn the powder into something you can draw into a syringe. It sounds technical but takes about a minute.

Once it is mixed, the only real question is how many units to draw. That depends on your vial size, your water amount, and your target dose, and it is easy to get wrong by hand.

  • Use bacteriostatic water, often called BAC water. The small amount of preservative keeps the mixed vial usable for weeks.
  • Add the water slowly, down the inside wall of the vial. A common mix is a 10 mg vial plus 2 mL of BAC water, which gives a concentration of 5 mg/mL.
  • Swirl, do not shake. Gently roll the vial until the powder dissolves. Shaking can damage the peptide.
  • Store it in the fridge once mixed, and keep it out of direct light.

Open the dosage calculator to turn your vial and dose into an exact number of units. As a worked example: a 10 mg vial mixed with 2 mL of BAC water gives 5 mg/mL, so a 3 mg dose is 0.6 mL, which is 60 units on a U-100 insulin syringe, and that vial holds about 3 doses at that level.

Dosing by goal.

There is no single official dose for mazdutide outside its Chinese approval, and the peptide vendors sell it for research use only. What follows is the titration pattern used in trials and discussed in the community. The defining feature of mazdutide dosing is the slow ramp up.

Starting phase

Almost every protocol starts low, around 1.5 mg once a week for the first few weeks, regardless of weight or prior GLP-1 experience. Starting higher mainly increases nausea and vomiting without improving results.

Titration phase

From there, the dose steps up every few weeks, typically through 3 mg and 4.5 mg. Each increase is where side effects tend to spike, so people hold at a level until they feel settled before going up again.

Maintenance phase

Most people settle at a 4 to 6 mg weekly maintenance dose, which is the range approved in China. Trials have studied 9 mg for higher weight loss, but the gut side effects climb with the dose.

Starting (first few weeks)
1.5 mg 1x/week

Everyone starts low to let the gut adjust. This is the gentle on-ramp, not where the results happen yet.

Maintenance (after titration)
4 to 6 mg 1x/week

The settled range most people run, matching the doses approved in China. Higher trial doses reach 9 mg but with more side effects.

Start-low rule: Mazdutide is dosed in milligrams and titrated slowly, so the schedule matters more than the number. Double-check your units on the calculator before you draw, and do not rush the ramp up just to chase faster results.

Cycling and timing.

Unlike a healing peptide that runs in short blocks, mazdutide is more like the other GLP-1 type compounds: it is taken continuously while you titrate up and then hold at a maintenance dose. There is no built-in loading-then-stopping rhythm.

The thing to plan for is what happens when you stop. As with other GLP-1 drugs, appetite tends to return when the compound leaves, so weight can come back without lasting habit changes. That is a conversation for a licensed provider, not a forum.

  • Hold each step until side effects settle before increasing the dose. The ramp up is the part to take slowly.
  • Keep the same day each week so blood levels stay steady. Consistency matters more here than with some peptides because of the glucagon arm.
  • Plan for stopping. Appetite returns when you come off, so think about the off-ramp before you start, ideally with a provider.
New to cycling? See how on and off periods, the washout, and keeping your results actually work.How cycling works →

Stacking Mazdutide.

Mazdutide is usually run on its own, because as a dual agonist it already covers two receptors. Still, a couple of combinations come up in the weight-loss space.

Maz + Cagrilintide

Appetite & satiety

Mazdutide Cagrilintide

Pairs the GLP-1 and glucagon dual agonist with cagrilintide, an amylin analog that works through a different appetite pathway. It mirrors the cagrilintide plus semaglutide combinations now in trials, layered for extra satiety.

View stack →
Maz solo

Standalone dual agonist

Mazdutide

The most common approach by far. Because mazdutide already hits two receptors, many people simply run it alone and titrate the dose rather than stacking anything on top.

View stack →

See full recipes, dosing, and how people run them on the stacks page.

Side effects and safety.

In the trials and reports we see, mazdutide's side effects are dominated by the gut, especially during dose increases, and they tend to ease as the body adjusts. The ones people mention most often are:

  • Nausea, the most common complaint, reported by a large share of users and worst right after a dose step-up.
  • Vomiting and diarrhea, which track with how fast the dose is raised.
  • Reduced appetite and early fullness, which is the intended effect but can tip into not eating enough.
  • Injection-site irritation, a little redness or a small bump, which is why rotating sites matters.
The honest limitation: long-term safety data outside the manufacturer's trials does not really exist yet, and those trials were run in Chinese adults. As with the whole GLP-1 class, there are open questions about muscle loss during rapid weight loss and effects after stopping. None of this replaces controlled, independent human data.

Who should be cautious.

Some people have clear reasons to be extra careful, or to avoid mazdutide entirely until they have spoken with a licensed provider.

  • Pregnant or breastfeeding. There is no safety data here, so this is a hard avoid.
  • A history of pancreatitis or gallbladder disease. GLP-1 type compounds are associated with these, so caution is widely advised.
  • A personal or family history of medullary thyroid cancer or MEN 2. The GLP-1 class carries warnings here, so this is a conversation for a doctor.
  • Anyone on other medications, especially diabetes drugs. Combining with insulin or sulfonylureas can drop blood sugar too far. Talk to your provider first.

And the universal one: whoever you are, talk to a licensed healthcare provider before starting mazdutide. This guide is educational, not a substitute for personalized medical advice.

Where to buy it safely.

This is where a lot of beginners get burned, because peptide quality varies wildly between vendors and the cheapest vial is not always the real deal. Our honest take: do not shop on price alone, shop on price plus independent lab data.

  • Compare vendors side by side. Price ranges are wide, and the difference between the lowest and highest listing can be large for the exact same compound.
  • Look for recent third-party lab tests. The gold standard the community looks for is a recent Janoshik certificate of analysis showing purity for the batch you are actually buying.
  • Favor recent COAs. An old lab result on a different batch tells you little. The fresher the test, the more it means.
  • Be skeptical of suspiciously cheap listings with no testing behind them.

That is exactly the comparison we put together. On our Mazdutide product page you can compare vendor prices, see which batches have public lab data, and view the grades we assign from that data. From there you can head to the buy page to line up your options.

A reminder on how we work: we aggregate public lab data and prices and compare vendors. We do not run labs, test products, or sell or ship peptides ourselves. Listing a vendor is not an endorsement.

Questions, answered straight.

Is Mazdutide legal?

Mazdutide is approved as a medicine only in China, and it is not approved by the FDA or EMA. The vendors we compare offer it strictly for research use only. It is not currently on WADA's prohibited list, though WADA added GLP-1 drugs to its monitoring list, so competing athletes should stay aware. Rules vary by country, so check what applies where you are.

How is it different from Semaglutide or Tirzepatide?

Semaglutide is a single GLP-1 agonist. Tirzepatide is a GLP-1 and GIP dual agonist. Mazdutide is a GLP-1 and glucagon dual agonist, and that glucagon arm is studied for raising energy expenditure rather than only cutting appetite, which is its main point of difference.

How much weight do people lose on it?

In trials, the highest doses reached roughly 18 to 20 percent body weight reduction over many weeks. Results depend heavily on dose, time, and the individual, and trial numbers are not a promise of what any one person will see.

How long until it works?

Effects build gradually as the dose is titrated up, over weeks to months rather than days. The early low-dose weeks are mostly about letting the gut adjust, not about results.

Does it need refrigeration?

Keep the sealed, freeze-dried vial frozen or refrigerated and out of light. Once you mix it with bacteriostatic water, store it refrigerated and use it within about four weeks. Do not freeze a reconstituted vial or put it through freeze-thaw cycles.

How do I figure out the dose in units?

Use our calculator. Enter your vial size, how much bacteriostatic water you added, and your target dose, and it tells you exactly how many units to draw on a U-100 syringe. The dosage calculator handles the math for you.

Ready to put this into practice?

You have got the full picture. Now compare what Mazdutide actually costs across vendors with lab data behind it, and work out your exact dose in seconds.

Just to be clear.

This site is for educational and informational purposes only and is not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease, and none of these statements have been evaluated by the FDA or any regulatory authority. Talk to a licensed healthcare provider before starting anything.

Peptides and other compounds referenced on this site are sold by third-party vendors strictly as research chemicals for laboratory and research use only. They are not drugs, dietary supplements, cosmetics, or products intended to diagnose, treat, cure, or be consumed by humans or animals, and nothing here is an offer to sell or any encouragement to use them in any such way. You must be at least 18 years old, and of legal age in your jurisdiction, to use this site. Clearly Peptides does not manufacture, sell, supply, or ship any peptides or compounds.

Lab data, grades, and prices are aggregated from publicly available third-party sources, primarily the Janoshik public database and finnrick, plus community-submitted reports. We don't run labs or test anything ourselves. We present this public information, credit each source, and link back to the original report so you can read it yourself. Listing a vendor or compound is not an endorsement.

Clearly Peptides participates in affiliate programs and may earn a commission when you buy through a link or code on this site, at no extra cost to you.

Clearly Peptides is not liable for any actions you take based on the information provided here. Your use of this site is subject to our Terms of Use.